NOTE 11 — FOREIGN CURRENCY FORWARD CONTRACTS

The Company enters into forward contracts to attempt to limit its exposure to foreign currency fluctuations. The Company recognizes in the balance sheet derivative contracts at fair value, and reflects any net gains and losses currently in earnings. At June 30, 2007, the Company held outstanding forward exchange positions for the purchase of euros, expiring through December 2007, in the amount of $815,380 with a weighted average conversion rate of €1 = $1.3590 as compared to the spot rate at June 30, 2007 of €1 = $1.3475. Gain or loss on foreign transactions, which was de minimus, is included in other income and expense.

NOTE 12 — PROVISION FOR INCOME TAXES

On January 1, 2007, the Company adopted the provisions of FIN 48 – Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109.  FIN 48 clarifies and sets forth consistent rules for accounting for uncertain tax positions in accordance with FAS 109, Accounting for Income Taxes.

As a result of the implementation of FIN 48, the Company made a review of its portfolio of uncertain tax positions in accordance with recognition standards established by FIN 48.  In this regard, an uncertain tax position represents the Company’s expected treatment of a tax position taken in a filed tax return, or planned to be taken in a future tax return, that has not been reflected in measuring income tax expense for financial reporting purposes.  As a result of this review, the Company determined that it had no material uncertain tax positions and, therefore, it has not recorded unrecognized tax benefits.  The Company does not expect any material changes to its uncertain tax positions.

The tax years 2004 through 2007 remain open to examination by federal and state tax jurisdictions.

The Company has various foreign subsidiaries for which tax years 2001 through 2007 remain open to examination in certain foreign tax jurisdictions.

The Company’s income tax benefit for the three-months ended June 30, 2007 and 2006 consists of federal and state and local taxes attributable to GCP which does not file a consolidated income tax return with the Company. In connection with the investment in GCP, the Company recorded a deferred tax liability on the ascribed value of the acquired intangible assets of $2,222,222, increasing the value of the asset. The deferred tax benefit is being recognized over the amortization period of the intangible asset (15 years). For each of the three-months ended June 30, 2007 and 2006, the Company recognized $37,038 of deferred tax benefit.

On December 1, 2003, the Company recorded a deferred tax liability of $629,444 as the amount ascribed to the difference between the book and tax basis of the tangible and intangible assets acquired as additional goodwill.

Pursuant to FIN 48, the Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes. The Company did not recognize any such interest and/or penalties during the three months ended June 30, 2007 and 2006.

NOTE 13 — STOCK OPTIONS AND WARRANTS

	A.	Stock Options – In July 2003, the Company implemented the 2003 Stock Incentive Plan (‘‘the Plan’’) which provides for awards of incentive and non-qualified stock options, restricted stock and stock appreciation rights for its officers, employees, consultants and directors in order to attract and retain such individuals who contribute to the Company’s success by their ability, ingenuity and industry knowledge, and to enable such individuals to participate in the long-term success and growth of the Company by giving them an equity interest in the Company. There are 2,000,000 common shares reserved and available for distribution under the Plan, of which 692,375 remain available. Stock options granted under the Plan are granted with an exercise price at or above the fair market value of the underlying common stock at the date of grant, generally vest over a four or five year period and expire ten years after the grant date.

14

Table of Contents

At June 30, 2007 total unrecognized compensation cost amounted to approximately $2,407,577, representing 669,775 unvested options. There were no options exercised under the share-based payment arrangements during the three-months ended June 30, 2007 and 2006.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model and is affected by assumptions regarding a number of highly complex and subjective variables. The use of an option pricing model also requires the use of a number of complex assumptions, including expected volatility, risk-free interest rate, expected dividends, and expected term. Expected volatility is based on the historical volatility of a peer group of companies over the expected life of the option as the Company does not have enough history trading as a public company to calculate its own stock price volatility. The expected term and vesting of the options represents the estimated period of time until exercise and is based on historical experience of similar awards, giving consideration to the contractual terms, vesting schedules and expectations of future employee behavior. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The Company has not paid dividends in the past and does not plan to pay any dividends in the near future. SFAS 123R also requires the Company to estimate forfeitures at the time of grant and revise these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates forfeitures based on its expectation of future experience while considering its historical experience.

A summary of the options outstanding under the stock option plan is as follows:

			Three-months ended June 30,
			2007												2006
			Shares						Weighted Average Exercise Price						Shares						Weighted Average Exercise Price
Outstanding at beginning of period					1,294,125					$	7.19						888,500					$	6.82
Granted					48,500						6.93						340,000						7.96
Forfeited					(35,000	)					6.51						—						—
Outstanding at end of period					1,307,625						7.20						1,228,500						7.14
Options exercisable at period end					655,450					$	7.11						405,267					$	6.63
Weighted average fair value of options granted during the period										$	3.23											$	3.46

The following table represents information relating to stock options outstanding at June 30, 2007:

			Options Outstanding												Options Exercisable
Range of Exercise Prices			Shares						Weighted Average Remaining Life in Years						Shares						Weighted Average Exercise Price						Aggregate Intrinsic value
$5.00 – $6.00					440,500						6.77						300,700					$	6.00					$	—
$6.01 – $7.00					129,500						9.74						12,125						6.93						—
$7.01 – $8.00					537,000						8.22						247,000						7.75						—
$8.01 – $9.00					200,625						9.04						95,625						9.00						—
					1,307,625						8.00						655,450						7.11					$	—

15

---

Table of Contents

The fair value of options at date of grant was estimated using the Black-Scholes option-pricing model utilizing the following weighted average assumptions:

			June 30, 2007						June 30, 2006
Risk-free interest rates					5.08	%			4.93 – 4.96%
Expected options life in years					7.00				7.00
Expected stock price volatility					50	%			75%
Expected dividend yield					0	%			0%

The following summarizes the activity of the Company’s stock options that have not vested for the three-months ended June 30, 2007:

			Shares						Weighted Average Exercise Price
Nonvested at April 1, 2007					720,500					$	7.21
Granted					48,500						6.93
Canceled or expired					(35,000	)					6.51
Vested					(81,825	)					7.25
Nonvested at June 30, 2007					652,175					$	7.29

As of June 30, 2007, there was $2,407,577 of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under existing stock option plans. This cost is expected to be recognized over a weighted-average period of 3.41 years. The total fair value of shares vested during the three-months ended June 30, 2007 and 2006 was $352,249 and $405,651, respectively.

Since no options were exercised, the Company did not recognize any tax benefit for the three-months ended June 30, 2007 and 2006.

B.    Stock Warrants – The Company has entered into various warrant agreements.

Common Stock Warrant Issued to the Financing Agent

On August 29, 2002, in connection with a revolving credit facility, the Company granted to the lender, Keltic Financial Partners, LP (‘‘Keltic’’), a warrant to acquire 100,000 shares of the Company’s common stock at an exercise price of $6.00. The warrant is subject to anti-dilution provisions, upon the occurrence of certain events such as stock splits and stock dividends, vests immediately and is exercisable through September 1, 2014. The warrant is exercisable at any time and includes a cashless exercise provision. The Company was not obligated to register the warrant or the underlying shares, except to the extent that, if the Company elected to file a registration statement, Keltic could have the shares underlying its warrant included in that registration statement and the Company would assume all registration costs and other expenses in connection with such registration.

On September 27, 2005, the warrant was amended to eliminate the cash put feature and replace it with certain penalties (up to $200,000) if the shares underlying the warrant were not been registered by June 1, 2007 and June 1, 2008. The Company agreed that if on either June 1, 2007 or June 1, 2008 (a) there were shares of common stock received or issuable upon the exercise of the warrant that have not been registered, and (b) it had not filed a registration statement with respect to which Keltic had the opportunity to register the unregistered shares, the Company would pay Keltic $100,000 within ten (10) days of such dates. The Company filed such registration statement on May 31, 2007, and Keltic elected to have the shares underlying its warrant included in such registration statement.

Effective with the Company’s registration statement (Reg. no. 333-143422), as amended, filed with the SEC on June 29, 2007 and declared effective on July 9, 2007, the registration rights penalty was eliminated. The Company has reflected the fair value of the combined instrument at March 31, 2007 included in the balance sheet caption accrued expenses, put warrants payable and derivative instrument of approximately $189,397.

16

---

Table of Contents

Common Stock Warrants Issued to Senior Note Holders

In connection with the issuance of the senior notes in November 2006, the Company entered into a warrant agreement to grant the right to purchase 213,600 shares of the Company’s common stock at an exercise price of $8.00 per share at any time through May 31, 2009. These warrants were recorded at relative fair value and accounted for as a discount to the face value of the senior notes and a credit to additional paid-in capital in the amount of $706,944. This discount will be recognized over the adjusted term of the senior notes with a charge to interest expense and a credit to senior notes payable. For the three-months ended June 30, 2007 and 2006, the Company recorded $24,521 and $5,148 of additional senior note accretion as additional interest expense.

Common Stock Warrants Issued to Financial Advisor

In July 2005, the Company granted to a financial advisor warrants to purchase up to 100,000 shares of common stock at $8.00 per share. The warrants are subject to anti-dilution provisions, such as stock splits and stock dividends, and vested upon the completion of the initial public offering in April 2006. The Company fair valued the warrant at $283,727 and recorded a charge upon vesting. The charge is included in interest expense for the three-months ended June 30, 2006 on the accompanying condensed consolidated statements of operations.

The following is a summary of the company’s outstanding warrants:

			Warrants						Weighted Average Exercise Price Per Warrant
Warrants outstanding and exercisable, March 31, 2007					812,218					$	7.75
Granted					1,443,214						6.57
Exercised					—						—
Forfeited					—						—
Warrants outstanding and exercisable, June 30, 2007					2,255,432					$	6.99

NOTE 14 — RELATED PARTY TRANSACTIONS

	A.	The Company is operating under an agreement with MHW, Ltd. (‘‘MHW’’) whereby MHW acts as the Company’s agent in the distribution of its products across the United States. MHW’s president also serves as a director of the Company and has a de minimus indirect ownership interest in the Company. In addition, MHW has a 10% ownership interest in the Celtic Crossing trade mark, one of the Company’s products, in the United States and its territories, Canada, Mexico, and the Caribbean.

Pursuant to the MHW distribution agreement, MHW receives sales orders from the Company’s domestic wholesalers at prices agreed upon with the Company. MHW simultaneously purchases Company inventory necessary to fill those orders and ships that inventory to the various wholesalers. MHW then invoices, collects, and deposits remittances from those wholesalers into an MHW bank account designated for the Company. The funds are remitted to the Company on a bi-weekly basis. Although MHW is responsible for the billing function, the collected funds are the property of the Company and MHW is not liable to the Company for any unpaid balances due from wholesalers.

In addition to the distribution services provided for the Company, MHW also provides administrative and support services on behalf of the Company. For the three-months ended June 30, 2007 and 2006, aggregate charges recorded for all services provided were approximately $74,023 and $59,707, respectively, which have been included in general and administrative expenses on the accompanying condensed consolidated statements of operations.

17

---

Table of Contents

	B.	The Company has transactions with Knappogue Corp., a stockholder in the Company. Knappogue Corp. is controlled by the Company’s CEO and his family. The transactions primarily involve rental fees for use of Knappogue Corp.’s interest in the Knappogue Castle for various corporate purposes including Company meetings and to entertain customers. For the three-months ended June 30, 2007 and 2006, fees incurred by the Company to Knappogue Corp. amounted to $13,487 and $0, respectively. These charges have been included in selling expense in the accompanying condensed consolidated statement of operations.

	C.	In April 2004, the Company contracted with BPW, Ltd., for business development services including providing introductions for the Company to agency brands that would enhance the Company’s portfolio of products and assisting the Company in successfully negotiating agency agreements with targeted brands. BPW, Ltd. is controlled by a director of the Company. For the three-months ended June 30, 2007 and 2006, the Company recognized expense of $12,668 and $9,326, respectively, under this contract. These charges have been included in general and administrative expense in the accompanying condensed consolidated statement of operations.

	D.	For the three-months ended June 30, 2006 and 2005, the Company purchased goods and services from Terra Manufacturing Limited (‘‘Terra’’) and Carbery Milk Products Limited (‘‘Carbery’’) of approximately $625,725 and $409,807, respectively. The Company had assumed the underlying supplier agreements with Terra and Carbery from CB-Ireland. Terra’s affiliate, Tanis Investments, and Carbery are both shareholders in the Company. As of June 30, and March 31, 2007, the Company was indebted to these two affiliates in the amount of approximately $538,449 and $668,097, respectively, which is included in due to stockholders and affiliates on the accompanying condensed consolidated balance sheet.

	E.	For the three-months ended June 30, 2007 and 2006, the Company made royalty payments of approximately $10,112 and $9,413, respectively, for use of a patent, to an entity that is owned by two stockholders in the Company. These charges have been included in other expense on the accompanying condensed consolidated statements of operations. The royalty agreement also includes the right to acquire the patent for the Trinity Bottle for €90,000 ($121,275) for the duration of the licensing period, which expires on December 1, 2008.

	F.	As discussed in Note 10, on April 18, 2007, the Company entered into a Securities Purchase Agreement with selected investors. The transaction closed on May 8, 2007. The Investors included, among others, three directors of the Company who collectively invested $1,671,630 in the offering.

18

---

Table of Contents

NOTE 15 — COMMITMENTS AND CONTINGENCIES

	A.	The Company has entered into a supply agreement with Irish Distillers Limited (‘‘Irish Distillers’’), which provides for the production of Irish whiskeys for the Company through 2017, subject to annual extensions on a rolling ten year basis. Under this agreement, the Company is obligated to notify Irish Distillers annually of the amount of liters of pure alcohol it requires for the current year and contracts to purchase that amount. For the calendar year ended December 31, 2007, the Company has contracted to purchase approximately €566,349 in bulk Irish whiskey. The Company is not liable to Irish Distillers for any product not yet received. During the term of this supply agreement Irish Distillers has the right to limit additional purchases above the commitment amount.

	B.	The Company has entered into a distribution agreement with Gaelic Heritage Corporation, Ltd. (‘‘Gaelic’’), an international supplier, to be the sole-producer of Celtic Crossing, one of the Company’s products, for an indefinite period.

	C.	In August 2004, Castle Brands entered into an agency agreement with I.L.A.R. S.p.A., the producer of Pallini Limoncello and its flavor extensions, to be the sole and exclusive importer of Pallini Limoncello and its flavor extensions throughout the United States and its territories and possessions. This agreement is subject to automatic renewal for as much as five years per renewal period upon Castle Brands achievement of contractual case sale targets. The agreement expires on December 31, 2009, unless the contractual case sales targets have been met.

Under this agreement, Castle Brands is permitted to import Pallini Limoncello and its flavor extensions at a set price, updated annually, and is obligated to set aside a portion of the gross margin toward a marketing fund for Pallini. The agreement also encompasses the hiring of a Pallini Brand Manager at Castle Brands with Pallini reimbursing the costs of this position up to a stipulated annual amount. These reimbursements are included in the accompanying condensed consolidated financial statements as a reduction in selling expense.

	D.	In September 2004, CB-USA entered into an exclusive distribution agreement with Gosling’s Export (Bermuda) Limited (‘‘GXB’’) to be the sole and exclusive importer of Gosling’s rum brands within the United States. Under this agreement, CB-USA will receive a net sales commission on each case sold. In February 2005, GXB sold its interest in the distribution agreement to Gosling-Castle Partners Inc.

CB-USA will receive a stipulated commission per case, subject to adjustment, provided certain case sales are achieved, for all sales in calendar years under the distribution agreement. The sales commission is net of agreed reimbursements, including taxes and payments to the marketing affiliate, GCP. This distribution agreement is for fifteen years, subject to extension.

The global distribution agreement commenced on April 1, 2005 and has a 15 year term. It is renewable for additional 15 year terms as long as GCP meets certain case sale targets during the initial term as set forth in the agreement. The Company ascribed the entire purchase of $5,000,000 to the Gosling global distribution agreement described above. In conjunction with this transaction the Company recorded a deferred tax liability of $2,222,222 to reflect the difference between the adjusted book value and tax basis. This deferred tax liability was recorded as an increase to the value of the distribution agreement and is included in intangible assets.

Castle Brands Inc. has agreed to fund certain operating losses of GCP. The balance funded at June 30, 2007 is approximately $2,500,000.

	E.	The Company subleases office space in Dublin, Ireland and New York, NY and leases office space in Houston, TX and Louisville, KY. The Dublin office lease commenced on June 1, 2004 and extends through February 28, 2009. Rent is payable quarterly in advance. The New York City lease commenced on August 15, 2004 and extends through

19

---

Table of Contents

		March 30, 2008. The Houston lease commenced on February 24, 2000 and extends through March 31, 2008. The Louisville lease commenced June 1, 2004, became effective for the Company concurrent with the acquisition of McLain & Kyne, Ltd., and expires May 31, 2009. The Company has also entered into non-cancelable operating leases for certain office equipment.

Future minimum lease payments are as follows:

For the years ending June 30,			Amount
2008				$	239,662
2009					5,265
Total				$	244,927

In addition to the above annual rental payments, the Company is obligated to pay its pro-rata share of utility and maintenance expenses on the leased premises. Rent expense under operating leases amounted to approximately $105,112 and $92,957 for the three-months ended June 30, 2007 and 2006 respectively, and is included in general and administrative expense on the accompanying condensed consolidated statements of operations.

	F.	Pursuant to the distribution agreement signed in March 1998 between the Company and Gaelic, which was amended and restated in April 2001, the Company, which currently owns 60% of the Celtic Crossing trademark in the United States, has the option to purchase 70% of the trademark outside the United States from Gaelic at a specified price adjusted by interim, annual changes in the Irish Consumer Price Index.

In the event of the sale of the brand rights by either the Company or Gaelic, the non-selling party shall have the right of first refusal to purchase the interest at the same price as the proposed sale and the right to sell alongside the other party.

Pursuant to the agreement, the Company is required to pay royalties to Gaelic for each case purchased, such royalties are included within cost of sales in the accompanying consolidated statements of operations.

	G.	Pursuant to a composite inter-company guarantee in the amount of €860,000 ($1,158,850) completed in February 2005 between the Company, Castle Brands Spirits Company Limited and Castle Brands Spirits (GB) Limited, the Company has guaranteed the loans from Ulster Bank to the Company’s European subsidiaries.

	H.	The Company is subject to strict government regulations associated with the marketing, importation, warehousing, transportation and distribution of spirits.

NOTE 16 — CONCENTRATIONS

	A.	Credit Risk – The Company maintains its cash and short-term investment balances at various large financial institutions that, at times, may exceed federally and internationally insured limits. As of June 30, and March 31, 2007, the Company exceeded the insured limit by approximately $20,000,000 and $6,400,000, respectively. Management believes the Company is not exposed to any significant credit risk because the institutions are international money center banking institutions with strong financial positions.

	B.	Suppliers – The Company has entered into a supplier agreement with Irish Distillers, Ltd., which provides for the production of single malt, blended and grain Irish whiskeys for the Company through 2015, with automatic renewal thereafter for successive five (5) calendar year renewal terms.

The Company has entered into a distribution agreement with Gaelic Heritage Corporation, Ltd. (‘‘Gaelic’’), an international supplier, to be the sole-producer of Celtic Crossing, one of the Company’s products, for an indefinite period.

20

---

Table of Contents

The Company has entered into a distribution agreement with ILAR, S.p.A (‘‘ILAR’’), an international supplier, to be the sole-producer of the Pallini premium Italian liqueurs, expiring December 31, 2009, subject to a three or five year renewal, depending on case purchase.

The Company has entered into a distribution agreement with Gosling’s Export (Bermuda) limited, an international supplier, to be the sole-producer of the Gosling’s family of rum products for 15 years.

The Company has entered into a supplier agreement with Carbery Milk Products Limited, an international supplier, which provides for the production of the Company’s vodka and cream products through December 31, 2008.

The Company has entered into a bottling and services agreement with Terra Limited which provides for the bottling of the Company’s vodka, whiskey and cream products through February 28, 2009.

	C.	Customers – Sales to one customer accounted for approximately 17.3% of the Company’s revenues for the three-months ended June 30, 2007 and approximately 27.2% of accounts receivable at June 30, 2007.

NOTE 17 —	LEGAL PROCEDINGS

The Company’s subsidiary, Castle Brands Spirits Company Limited, is the holder of a trademark registration for the mark ‘‘BORU’’ with the United States Patent and Trademark Office. On May 9, 2007, Distillerie Stock U.S.A. Ltd. filed a Petition for Cancellation with the United States Patent and Trademark Office for the cancellation of the trademark registration for BORU on several grounds, including potential confusion between BORU and its existing registered trademark ‘‘BORA’’. The Company has filed a response presenting various defenses on the merits as well as procedural defenses in a timely manner against Distillerie Stock’s claims. The Company intends to vigorously pursue these defenses as appropriate. Currently, the matter is pending at the United States Patent and Trademark Office before the Trademark Trial and Appeal Board. While matters before the Trademark Trial and Appeal Board cannot result in monetary damages or directly affect the right to use a trademark, they can result in the cancellation of a trademark registration. Thus, it is possible this matter could result in the cancellation of the Company’s trademark registration for BORU in the United States. As a result, it is not feasible to predict the final outcome, and there can be no assurance that these claims might not be finally resolved adversely to the Company, resulting in material liability to its operations.

NOTE 18 — GEOGRAPHIC INFORMATION

The Company operates in one business – premium branded spirits. The Company’s product categories are vodka, rum, liqueurs/cordials, and whiskey and reports its operations in two geographic areas: International and United States.

The condensed consolidated financial statements include revenues and assets generated in or held in the U.S. and foreign countries. The following table sets forth the percentage of consolidated revenue and consolidated assets from the U.S. and foreign countries.

21

---

Table of Contents

			For the three-months ended June 30,
			2007												2006
Consolidated Revenue:
International				$	1,703,630						30.3	%				$	1,883,044						34.5	%
United States					3,920,455						69.7	%					3,577,361						65.5	%
Total Consolidated Revenue				$	5,624,085						100	%				$	5,460,405						100	%
Consolidated Depreciation and Amortization:
International				$	21,573						7.9	%				$	18,942						8.1	%
United States					249,854						92.1	%					215,552						91.9	%
Total Consolidated Depreciation and Amortization				$	271,427						100	%				$	234,494						100	%
Income Tax Benefit:
United States					37,038						100	%					37,038						100	%
Revenues by Category:
Vodka				$	1,640,935						29.2	%				$	1,837,963						33.7	%
Rum					2,088,813						37.1	%					1,806,076						33.1	%
Liqueurs/Cordials					1,048,790						18.7	%					1,050,124						19.2	%
Whiskey					762,043						13.5	%					728,083						13.3	%
Other*					83,504						1.5	%					38,159						0.7	%
Total Consolidated Revenue				$	5,624,085						100	%				$	5,460,405						100	%
Consolidated Assets:
International				$	6,035,598						8.7	%
United States					62,971,746						91.3	%
Total Consolidated Assets				$	69,007,344						100.0	%

*	Includes related food products.

22

---

Table of Contents

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward Looking Statements

This Quarterly Report on Form 10-Q includes statements of our expectations, intentions, plans and beliefs that constitute ‘‘forward-looking statements’’ within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to come within the safe harbor protection provided by those sections. These statements, which involve risks and uncertainties, relate to the discussion of our business strategies and our expectations concerning future operations, margins, profitability, liquidity and capital resources and to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable. We have used words such as ‘‘may,’’ ‘‘will,’’ ‘‘should,’’ ‘‘expects,’’ ‘‘intends,’’ ‘‘plans,’’ ‘‘anticipates,’’ ‘‘believes,’’ ‘‘thinks,’’ ‘‘estimates,’’ ‘‘seeks,’’ ‘‘expects,’’ ‘‘predicts,’’ ‘‘could,’’ ‘‘projects,’’ ‘‘potential’’ and other similar terms and phrases, including references to assumptions, in this report to identify forward-looking statements. These forward-looking statements are made based on expectations and beliefs concerning future events affecting us and are subject to uncertainties, risks and factors relating to our operations and business environments, all of which are difficult to predict and many of which are beyond our control, that could cause our actual results to differ materially from those matters expressed or implied by these forward-looking statements. These risks and other factors include those listed under ‘‘Risk Factors’’ in our Annual Report on Form 10-K for the year ended March 31, 2007 and elsewhere in this report. The following factors, among others, could cause our actual results and performance to differ materially from the results and performance projected in, or implied by, the forward-looking statements:

	•	our history of losses and expectation of further losses;

	•	the effect of poor operating results on our company;

	•	the effect of growth on our infrastructure, resources and existing sales;

	•	our ability to expand our operations in both new and existing markets and our ability to develop or acquire new brands;

	•	the impact of supply shortages and alcohol and packaging costs in general;

	•	our ability to raise capital;

	•	our ability to fully utilize and retain new executives;

	•	negative publicity surrounding our products or the consumption of beverage alcohol products in general;

	•	our ability to acquire and/or maintain brand recognition and acceptance;

	•	trends in consumer tastes;

	•	our ability to protect trademarks and other proprietary information;

	•	the impact of litigation;

	•	the impact of federal, state, local or foreign government regulations;

	•	the effect of competition in our industry; and

	•	economic and political conditions generally.

We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in, or implied by, these forward-looking statements, even if new information becomes available in the future.

23

---

Table of Contents

Currency Translation

The functional currencies for our foreign operations are the euro in Ireland and continental Europe the British pound in the United Kingdom and the Canadian dollar in Canada. With respect to our condensed consolidated financial statements, the translation from the applicable foreign currencies to U.S. dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. The resulting translation adjustments are recorded as a component of other comprehensive income. Gains or losses resulting from foreign currency transactions are included in other income/expenses.

Where in this quarterly report we refer to amounts in euros, British pounds or Canadian dollars we have for your convenience also in certain cases provided a translation of those amounts to U.S. dollars in parenthesis. Where the numbers refer to a specific balance sheet account date or financial statement account period, we have used the exchange rate that was used to perform the translations in connection with the applicable financial statement. In all other instances, unless otherwise indicated, the translations have been made using the exchange rates as of June 30, 2007, each as calculated from the Interbank exchange rates as reported by Oanda.com. On June 30, 2007, the exchange rate of the euro, the British pound and the Canadian dollar in exchange for U.S. dollars were €1.00 = U.S. $1.34754 (equivalent to U.S. $1.00 = €0.74209) for euros, £1.00 = U.S. $2.00393 (equivalent to U.S. $1.00 = £0.49902) for British Pounds, and CAN $1.00 = U.S. $0.94431 (equivalent to U.S. $1.00 = CAN $1.05897) for Canadian dollars, respectively.

These translations should not be construed as representations that the euro, British pound and Canadian dollar amounts actually represent U.S. dollar amounts or could be converted into U.S. dollars at the rates indicated.

The following information should be read in conjunction with ‘‘Management’s Discussion and Analysis of Financial Condition and Results of Operations’’ and the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended March 31, 2007, as well as in conjunction with the condensed consolidated financial statements and related notes appearing elsewhere in this Form 10-Q.

Overview

We develop and market premium branded spirits in several growing market categories, including vodka, rum, whiskey and liqueurs, and we distribute these spirits in all 50 U.S. states and the District of Columbia, in six key international markets, including Ireland, Great Britain, Northern Ireland, Germany, Canada and the Duty Free markets, and in a number of other countries in continental Europe. The brands we market include, among others, Boru vodka, Gosling’s rum, Clontarf Irish Whiskey, Knappogue Castle Whiskey, Jefferson’s, Jefferson’s Reserve and Sam Houston bourbons, Celtic Crossing and the Pallini liqueurs.

Our current growth strategy focuses on: (a) aggressive brand development to encourage case sale and revenue growth of our existing portfolio of brands through significant investment in sales and marketing activities, including advertising, promotion and direct sales personnel expense; and (b) the selective addition of complementary premium brands through a combination of strategic initiatives, including acquisitions, joint ventures and long-term exclusive distribution arrangements.

24

---

Table of Contents

Financial performance overview

The following table sets forth certain information regarding our case sales for the quarters ended June 30, 2007 and 2006. The data in the following table is based on nine-liter equivalent cases, which is a standard spirits industry metric.

			Three-months Ended June 30,
Case Sales			2007						2006
Cases
United States					44,723						42,530
International					29,447						27,965
Total					74,170						70,495
Vodka					35,997						33,864
Rum					22,770						19,863
Liqueurs/cordials					10,418						11,905
Whiskey					4,985						4,863
Total					74,170						70,495
Percentage of Cases
United States					60.3	%					60.3	%
International					39.7						39.7
Total					100.0	%					100.0	%
Vodka					48.5	%					48.0	%
Rum					30.7						28.2
Liqueurs/cordials					14.1						16.9
Whiskey					6.7						6.9
Total					100.0	%					100.0	%

Critical accounting policies and estimates

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of sales and expenses during the reporting period. On an ongoing basis, we evaluate these estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable under the circumstances; however, actual results may differ from these estimates under different future conditions.

We believe that the estimates and assumptions discussed below are most important to the portrayal of our financial condition and results of operations in that they require our most difficult, subjective or complex judgments and form the basis for the accounting policies deemed to be most critical to our operations.

Revenue recognition

We recognize revenue from product sales when the product is shipped to a customer (generally upon shipment to a distributor or to a control state entity), title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination) and collection is reasonably assured. We do not offer a right of return but will accept returns if we shipped the wrong product or wrong quantity.

Accounts receivable

We record trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated on the trade accounts

25

---

Table of Contents

receivable balances and charged to the provision for doubtful accounts. We calculate this allowance based on our history of write-offs, level of past due accounts based on contractual terms of the receivables and our relationships with, and economic status of, our customers.

Inventory

Our inventory, which consists of distilled spirits, packaging and finished goods, is valued at the lower of cost or market, using the weighted average cost method. We assess the valuation of our inventories and reduce the carrying value of those inventories that are obsolete or in excess of our forecasted usage to their estimated realizable value. We estimate the net realizable value of such inventories based on analyses and assumptions including, but not limited to, historical usage, future demand and market requirements. Reduction to the carrying value of inventories is recorded in cost of goods sold.

Goodwill and other intangible assets

Goodwill represents the excess of purchase price and related costs over the value assigned to the net tangible and other intangible assets of businesses acquired. As of both June 30, and March 31, 2007, goodwill and other intangible assets that arose from acquisitions were $13.0 million. Goodwill and other intangible assets with indefinite lives are not amortized, but instead, are tested for impairment annually or, more frequently, if circumstances indicate a possible impairment may exist.

We evaluate the recoverability of goodwill and indefinite lived intangible assets using a two-step impairment test approach at the reporting unit level. In the first step the fair value of the reporting unit is compared to its book value including goodwill. In the case that the fair value of the reporting unit is less than the book value, a second step is performed which compares the implied fair value of the reporting unit’s goodwill to the book value of the goodwill. The fair value for the goodwill is determined based on the difference between the fair values of the reporting units and the net fair values of the identifiable assets and liabilities of such reporting units. If the fair value of the goodwill is less than the book value, the difference is recognized as an impairment.

SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives to the estimated residual values and reviewed for impairment in accordance with SFAS No. 144, ‘‘Accounting for the Impairment or Disposal of Long-Lived Assets.’’

Stock-based compensation

The Company follows Statement of Financial Accounting Standards (‘‘SFAS’’) No. 123R, ‘‘Share Based Payment.’’ SFAS 123R requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with SFAS 123R.

No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets. We follow the alternative method of calculating the historical pool of windfall tax benefits as permitted by FASB Staff Position (FSP) No. SFAS 123R, ‘‘Transition Election Related to Accounting for the Tax Effects of Share-Based Payment Awards.’’ This is a simplified method to determine the pool of windfall tax benefits that is used in determining the tax effects of stock compensation in the results of operations and cash flow reporting for outstanding awards.

Stock based compensation for the three-months ended June 30, 2007 and 2006 was $0.3 million and $0.5 million, respectively. We used the Black-Scholes option-pricing model to estimate the fair value of options granted. The assumptions used in valuing the options granted during the three months ended June 30, 2007 and 2006 are included in Note 13 to the condensed consolidated financial statements.

26

---

Table of Contents

Fair value of financial instruments

SFAS No. 107, ‘‘Disclosures About Fair Value of Financial Instruments,’’ defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. We believe that there is no material difference between the fair value and the reported amounts of financial instruments in the balance sheets due to the short-term maturity of these instruments, or with respect to the debt, as compared to the current borrowing rates available to us.

Results of operations

The following table sets forth, for the periods indicated, the percentage of net sales of certain items in our financial statements.

			Three-months ended June 30,
			2007						2006
Sales, net					100.0	%					100.0	%
Cost of sales					62.3	%					65.3	%
Gross profit					37.7	%					34.7	%
Selling expense					75.3	%					64.9	%
General and administrative expense					36.6	%					40.9	%
Depreciation and amortization					4.8	%					4.3	%
Loss from continuing operations					(79.1	)%					(75.4	)%
Other income					0.0	%					0.0	%
Other expense					(0.2	)%					(0.1	)%
Foreign exchange gain					1.4	%					7.3	%
Interest expense, net					(8.7	)%					(7.8	)%
Write-off of deferred financing costs in connection with conversion of 6% subordinated convertible notes					0.0	%					(5.4	)%
Current credit/(charge) on derivative financial instrument					3.4	%					0.0	%
Income tax benefit					0.7	%					0.7	%
Minority interests					4.3	%					6.3	%
Net loss					(78.3	)%					(74.4	)%
Less:
Preferred stock dividends					0.0	%					0.9	%
Net loss attributable to common stockholders					(78.3	)%					(75.3	)%

Three-months Ended June 30, 2007 Compared With Three-months Ended June 30, 2006

Net sales.    Net sales increased $0.2 million, or 3.0%, to $5.6 million in the three-months ended June 30, 2007 from $5.4 million in the comparable prior period. During the three-months ended June 30, 2007, we began to increase the price of certain of our products as a part of our overall pricing strategy. Our increase in net sales reflects the initial effects of some of these price increases as well as an increase in overall case sales, primarily from existing brands. The weakening dollar vis-à-vis the euro and the British pound also positively impacted our net sales as our international sales which are denominated in euros and British pounds translated to U.S. dollars at a higher rate. However, some of these net sales gains were offset by reduced net sales from direct imports into the U.S., whereby federal excise taxes are paid directly by the distributor, resulting in lower revenue per case.

Our U.S. case sales as a percentage of total case sales remained flat at 60.3% during the three-months ended June 30, 2007 against the comparable period in 2006.

The table below presents the increase or decrease, as applicable, in our case sales by product category for the three-months ended June 30, 2007 as compared to the prior year period. Current

27

---

Table of Contents

period Whiskey case sales include sales of bourbon products following our acquisition of McLain & Kyne on October 12, 2006. In fiscal 2007, we elected to discontinue sales of a low-margin Irish cream, which resulted in a decrease in the sales of liqueurs:

			Increase in case sales												Percentage increase
			Overall						U.S.						Overall						U.S.
Vodka					2,133						4,085						6.3	%					28.4	%
Rum					2,907						(863	)					14.6	%					(5.5	)%
Liqueurs/cordials					(1,487	)					1,166						(12.5	)%					(19.5	)%
Whiskey					122						(2,195	)					2.5	%					15.7	%
Total					3,675						2,193						5.2	%					2.9	%

Gross profit.     Gross profit increased 11.8% to $2.1 million during the three-months ended June 30, 2007 from $1.9 million in the comparable prior period, while our gross margin increased to 37.7% during the three-months ended June 30, 2007 compared to 34.7% for the comparable prior period.

The absolute increase in gross profit reflected our increased level of sales. The increase in gross margin percentage is a result of price increases across certain of our products as a part of our overall pricing strategy, coupled with a change in product mix to some of the higher margin products, including shifts in both brands and sizes. These increases were partially offset by the adverse effects of the weakening dollar vis-à-vis the euro and the resulting increase in real U.S. dollar costs of our euro billed production.

Selling expense.     Selling expense increased 19.6% to $4.2 million in the three-months ended June 30, 2007 from $3.5 million in the comparable prior year period. This increase in selling expense was attributable to the expansion, growth and continued support of our brands and increased case sales, including increases in distributor incentives and sales support costs of $0.2 million. The increase to these costs was offset in part by a contraction of certain advertising campaigns of $0.2 million. In order to strengthen our sales and marketing team, we added new personnel, which resulted in an increase in consultancy and compensation expense of $0.4 million. Stock-based compensation expense attributable to sales and marketing personnel remained flat at $0.1 million in the three-months ended June 30, 2007 when compared to the comparable prior period. As a result of the foregoing, selling expense as a percentage of net sales increased to 75.3% in the three-months ended June 30, 2007 as compared to 64.9% for the comparable prior year period.

General and administrative expense.    General and administrative expense decreased 7.8% to $2.1 million in the three-months ended June 30, 2007 from $2.2 million in the comparable prior year period. The decrease in general and administrative expense was primarily attributable a decrease in stock-based compensation to $0.2 million in the three-months ended June 30, 2007 from $0.4 million in the comparable prior year period. This decrease in stock-based compensation was due to a one-time charge for options issued in May 2006 that vested upon issuance. However, such decrease was offset by small increases in compensation, occupancy and capital based taxes. As a result of the foregoing, general and administrative expense as a percentage of net sales decreased to 36.6% in the three-months ended June 30, 2007 compared to 40.9% for the comparable prior year period.

Depreciation and amortization.    Depreciation and amortization during the quarter ended June 30, 2007 was approximately the same as the comparable prior year quarter at $0.3 million.

Other Income/(Expense), Net.    Other income/(expense), net, remained flat at $0.1 million during the three-months ended June 30, 2007 when compared to the comparable prior year period. The major components of this category include a change in foreign exchange, net interest income/(expense) and minority interest.

Foreign exchange gain during the three-months ended June 30, 2007 was $0.1 million as compared to $0.4 million in the comparable prior period. The lower gain in the current period is

28

---

Table of Contents

attributable to the slowing of the strengthening of the euro and the British pound against the dollar, as compared to the comparable prior year period, on our intercompany loans to our foreign subsidiaries.

Interest income during the three-months ended June 30, 2007 was $0.1 million as compared to $0.2 in the comparable prior year period. The source of this income for the quarter ended June 30, 2007 is the investment of our available cash in short-term investments. Interest expense during the three-months ended June 30, 2007 was $0.6 million versus $0.9 million in the comparable prior year period. The decrease in interest expense is primarily attributable to the vesting of certain warrants treated as interest expense of $0.3 million in April 2006.

Minority interest during the three-months ended June 30, 2007 amounted to a credit of $0.2 million as compared to a credit of $0.3 million in the comparable prior year period as a result of improving operations recorded by our 60%-owned subsidiary, Gosling-Castle Partners, Inc.

Net loss attributable to common stockholders.     The net loss attributable to common stockholders for the three-months ended June 30, 2007 increased 7.1% to $4.4 million from $4.1 million in the comparable prior year period. Net loss per common share basic and diluted was positively affected by the increase in shares outstanding resulting from the shares issued in our private placement completed in May 2007. The net loss per common share for the three-months ended June 30, 2007 include no preferred dividends as compared to $0.1 million of preferred stock dividends accrued during the comparable prior year period.

EBITDA.    As a result of the foregoing, EBITDA decreased 28.6% to negative $3.4 million for the three-months ended June 30, 2007 versus negative $2.7 million the comparable prior year period. EBITDA represents net income before deducting interest expense (including expensing of deferred financing costs), income taxes, depreciation and amortization and the impact of the non-cash charge for stock-based compensation reported under SFAS 123(R). We use EBITDA as the primary internal management measure for evaluating performance on a period over period analysis, when comparing actual results to budgeted performance and when allocating additional resources. This non-GAAP financial measure is presented in order to assist industry analysts and investors in assessing our liquidity, our ability to incur and service debt, make capital expenditures and meet working capital requirements. EBITDA should not be considered as an alternative to operating income as an indicator of our performance, as an alternative to cash flows from operating activities as a measure of liquidity, or as an alternative to any other measure determined in accordance with GAAP. Unlike net income, EBITDA does not include depreciation or interest expense and therefore does not reflect current or future capital expenditures or the cost of capital. We compensate for these limitations by using EBITDA as only one of several comparative tools, together with GAAP measurements, to assist in the evaluation of operating performance. Such GAAP measurements include operating income (loss), net income (loss), cash flows from operations and cash flow data. We have significant uses of cash flows, including interest payments, debt principal repayments, and other non-recurring charges, which are not reflected in EBITDA. Because EBITDA as determined by us excludes some, but not all, items that affect net income, it may not be comparable to EBITDA or similarly titled measures used by other companies.

29

---

Table of Contents

The following table sets forth our reconciliation of EBITDA to net loss (the most directly comparable financial measure):

			Three-months Ended June 30,
(Dollars in thousands)			2007						2006
Net loss				$	(4,405	)				$	(4,064	)
Add (subtract):
Income tax benefit					(37	)					(37	)
Interest expense, net, including expensing of deferred financing costs					488						718
Depreciation and amortization					271						234
Stock based compensation					270						494
EBITDA				$	(3,413	)				$	(2,655	)

Liquidity and capital resources

Since our inception, we have incurred significant operating and net losses and, in addition, have not generated positive cash flows from operations. As of June 30, 2007, we had stockholders’ equity of $39.0 million and working capital of $32.6 million as compared to $23.6 million and $17.1 million, respectively, at March 31, 2007. These increases are a result of our May 2007 private placement.

Our private placement in May 2007 raised net proceeds of $19.6 million upon the sale of 3,520,035 common shares at the offering price of $5.97 per share. The proceeds have been and will continue to be used for working capital and general corporate purposes, including, without limitation, sales and marketing activities.

At June 30, 2007, we had cash and cash equivalents and short-term investments of approximately $20.0 million compared to $6.9 million at March 31, 2007. This $13.1 million increase is primarily attributable to our May 2007 private placement net of our operating capital needs. In addition, at June 30, 2007, we had approximately $0.5 million of cash restricted from withdrawal and held by a bank in Ireland as collateral for a line of credit.

The following trends are reasonably likely to result in a material decrease in our liquidity over the near-to-mid term:

	•	an increase in working capital requirements to finance higher levels of inventories and accounts receivable;

	•	addition of administrative and sales personnel as our business expands;

	•	increases in advertising, public relations and sales promotions for existing and new brands;

	•	acquisition of additional spirits brands;

	•	an increase in legal, accounting and other expenses due to our status as a public company;

	•	financing the operations of our 60%-owned Gosling-Castle Partners strategic export venture; and

	•	expansion into new markets and within existing markets in the United States and internationally.

We expect that we will require increasing amounts of working capital to finance our inventory levels in the United States. Except for Gosling’s rums and our bourbon products, which are bottled in the United States, all of our products are imported from Europe. In the case of our internationally produced brands, there is a three-to-four month production and shipping lead time between the time of order placement and the time the product is available for sale. This lead time has required us to maintain sufficient inventories to properly service our customers.

We expect to experience a lengthening of the revenue collection cycle due to the need to extend payment terms as an incentive to encourage customers to make container-sized purchases of our products on which title passes to the customer at the shipping point in Ireland. A lengthening of the revenue collection cycle will require a significant amount of working capital.

30

---

Table of Contents

Cash flows

The following table summarizes our primary sources and uses of cash during the periods presented (in thousands):

			Three-months Ended June 30,
			2007						2006
Net cash provided by (used in):
Operating activities				$	(7,428	)				$	(6,366	)
Investing activities					1,853						(20,579	)
Financing activities					20,499						25,557
Net increase in cash and cash equivalents				$	14,924					$	(1,388	)

Operating activities.    A substantial portion of our available cash has been used to fund our operating activities. In general, these cash funding requirements are based on operating losses, driven chiefly by our sizable investment in selling and marketing. With increases in our overall sales volumes, we have also utilized cash to fund our receivables and inventories. In general, these increases are only partially offset by increases in our accounts payable to our suppliers and accrued expenses. Our business has incurred significant losses since inception.

On average, the production cycle for our owned brands can take as long as four months from the time we obtain the distilled spirits and other materials needed to bottle and package our products to the time we receive products available for sale, which is impacted by the international nature of our business. With respect to Gosling’s rums and Pallini liqueurs, we do not produce the finished product and, instead, receive the finished product directly from the owners of such brands. From the time we have products available for sale, an additional three to four months may be required before we sell our inventory and collect payment from our customers.

In the quarter ended June 30, 2007, net cash used in operating activities was $7.4 million, consisting primarily of losses from our operations of $4.4 million, increases in inventories and prepaid expenses of $1.3 million and $0.6 million, respectively, decreases in accounts payable and accrued expenses and due to related parties of $1.3, $0.1 million resulting from the effect of changes in foreign currency rates, and minority interest in the net loss of our 60%-owned subsidiary Gosling-Castle Partners of $0.2 million. These uses of cash were offset, in part, by a decrease in accounts receivable of $0.1 million, and by non-cash charges for depreciation and amortization and stock-based compensation expense of $0.3 million and $0.3 million, respectively.

In the quarter ended June 30, 2006, net cash used in operating activities was $6.4 million, consisting primarily of losses from our operations of $4.1 million, an increase in accounts receivable of $1.0 million, increases in inventories and prepaid expenses of $0.8 million and $0.4 million, respectively, decreases in accounts payable and accrued expenses and due to related parties of $0.7, $0.4 million resulting from the effect of changes in foreign currency rates, and minority interest in the net loss of our 60%-owned subsidiary Gosling-Castle Partners of $0.3 million. These uses of cash were offset, in part, by non-cash charges for depreciation and amortization and stock-based compensation expense of $0.2 million and $0.5 million, respectively, as well as a non-cash interest charge of $0.3 million upon the vesting of warrants issued to a financial advisor of the company, and to the write-off of $0.3 million of deferred financing costs due to the conversion to common stock of 40% of our 6% convertible subordinated notes at the time of our initial public offering.

Investing activities.    We fund certain acquisitions and operating activities primarily with cash and short-term investments. Net cash provided by investing activities was $1.9 million during the three-months ended June 30, 2007, consisting of the proceeds from sale of certain short-term investments of $2.0 million and acquisitions of property and equipment and intangible assets of $0.1 million.

Net cash used in investing activities during the quarter ended June 30, 2006 was $0.2 million for the acquisition of property and equipment and intangible assets.

31

---

Table of Contents

Financing activities.    Net cash provided by financing activities during the three-months ended June 30, 2007 was $20.5 million and consisted of $21.0 million of common stock issued in our private placement less $0.1 million in payments for the costs of stock issuance and the net repayment of notes payable in the amount of $0.4 million.

Net cash provided by financing activities during the quarter ended June 30, 2006 was $25.6 million and consisted of $31.5 million of common stock issued in our initial public offering less $3.0 million in payments for the costs of stock issuance and the net repayment of notes payable in the amount of $2.9 million.

We believe that we will be able to fund our operations from the proceeds of our private placement, our projected cash flow from operations, and current cash and cash equivalents for the at least the next twelve months. Beyond that, additional financing may be needed to fund working capital and other requirements. Changes in our operating plans, acquisitions or other additions of brands, lower than anticipated sales, increased expenses, or other events, including those described in our Annual Report on Form 10-K for the year ended March 31, 2007, under the caption ‘‘Risk Factors,’’ may require us to seek additional debt or equity financing on an accelerated basis. Financing may not be available on acceptable terms, or at all, and our failure to raise capital when needed could impact negatively our growth plans, financial condition and results of operations. Additional equity financing may be dilutive to the holders of our common stock, and debt financing, if available, may involve significant cash payment obligations or financial covenants and ratios that restrict our ability to operate our business.

Contractual obligations

The following table sets forth our contractual commitments as of June 30, 2007 for each of the following years:

			Payments due during the year ending June 30,
			2008						2009						2010						2011						2012						Thereafter						Total
			(in thousands)
Long-term notes payable, including current portion and estimated interest Ulster Bank facilities				$	25					$	—					$	—					$	—					$	—					$	—					$	25
9% senior notes					—						10,000						—						—																		10,000
6% convertible subordinated notes					—						—						9,000						—						—						—						9,000
Capital leases					4						4						0						—																		8
Operating leases					240						5						—						—						—						—						245
Total				$	269					$	10,009					$	9,000					$	—					$	—					$	—					$	19,278

Recent accounting pronouncements

In September 2006, the FASB issued SFAS No. 157, ‘‘Fair Value Measurements,’’ to define fair value, establish a framework for measuring fair value in accordance with generally accepted accounting principles, and expand disclosures about fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007, the beginning of the Company’s 2008 fiscal year. The Company is assessing the impact the adoption of SFAS No. 157 will have on the Company’s financial position and results of operations.

In February 2007, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 159, ‘‘The Fair Value Option for Financial Assets and Financial Liabilities’’ (SFAS 159), which allows an entity the irrevocable option to elect fair value for the initial and subsequent measurement for certain financial assets and liabilities on a contract-by-contract basis. Subsequent changes in fair value of these financial assets and liabilities would be recognized in earnings when they occur. SFAS 159 further establishes certain additional disclosure requirements. SFAS 159 is effective for fiscal years beginning after November 15, 2007, with earlier adoption permitted. Management is currently evaluating the impact and timing of the adoption of SFAS 159 on our consolidated financial statements.

32

---

Table of Contents

Item 3.    Quantitative and Qualitative Disclosures about Market Risk

As of June 30, 2007, we did not participate in any derivative financial instruments, or other financial or commodity instruments for which fair value disclosure would be required under SFAS No. 107, Disclosure About Fair Value of Financial Investments. We hold no investment securities that would require disclosure of market risk.

Our short-term investments consist primarily of auction rate corporate debt, auction rate municipal securities, government bonds, mutual funds and preferred stock that are highly liquid in nature and represent the investment of cash that is available for current operations. Although original maturities of the Company’s auction rate securities are generally longer than one year, the Company has the right to sell these securities each auction date subject to the availability of buyers. Interest rates on these securities reset at every auction date, generally every twenty eight days. As the estimated fair value of these short-term investments approximates the carrying cost, no disclosure of market risk is required.

We do participate in certain foreign exchange currency future contracts programs to limit our risk and the potential impact of currency fluctuations on our product costs. When placing a product order, we attempt to lock in its cost by buying forward contracts on euros coinciding with the projected payment dates for such purchases. Individual forward contracts rarely extend for more than six months or exceed €300,000 ($404,250). At June 30, 2007 total forward contracts outstanding amounted to €600,000 ($815,380), calculated at the weighted average conversion rate in such contracts). Depending upon the term of the contract, the cost of these transactions can vary between approximately 50 to 150 basis points.

Item 4.    Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Security Exchange Act of 1934, as amended (the ‘‘Exchange Act’’)) that are designed to ensure that information that would be required to be disclosed in Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Security Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and President, Chief Operating Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

As of June 30, 2007, we carried out an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and President, Chief Operating Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. This type of disclosure controls evaluation is performed on a quarterly basis so that the conclusions of management, including the Chief Executive Officer and President, Chief Operating Officer and Principal Financial Officer, concerning the effectiveness of controls can be reported in our Quarterly Reports on Form 10-Q and in our Annual Reports on Form 10-K. Many of the components of our disclosure controls are also evaluated on an ongoing basis by other personnel in our accounting, finance and legal functions. The overall goals of these various evaluation activities are to monitor our disclosure controls and to modify them on an ongoing basis as necessary. Based upon the evaluation of our disclosure controls, our Chief Executive Officer and President, Chief Operating Officer and Principal Financial Officer concluded that our disclosure controls were effective as of June 30, 2007 to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the period covered by this Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

33

---

Table of Contents

PART II.    OTHER INFORMATION

Item 1.    Legal Proceedings

Except as described below, we believe that neither we nor any of our wholly owned subsidiaries is currently subject to litigation which, in the opinion of our management, is likely to have a material adverse effect on us.

Our subsidiary, Castle Brands Spirits Company Limited, is the holder of a trademark registration for the mark ‘‘BORU’’ with the United States Patent and Trademark Office. On May 9, 2007, Distillerie Stock U.S.A. Ltd. filed a Petition for Cancellation with the United States Patent and Trademark Office for the cancellation of the trademark registration for BORU on several grounds, including potential confusion between BORU and its existing registered trademark ‘‘BORA’’. We have filed a response presenting various defenses on the merits as well as procedural defenses in a timely manner against Distillerie Stock’s claims. We intend to vigorously pursue these defenses as appropriate. Currently, the matter is pending at the United States Patent and Trademark Office before the Trademark Trial and Appeal Board. While matters before the Trademark Trial and Appeal Board cannot result in monetary damages or directly affect the right to use a trademark, they can result in the cancellation of a trademark registration. Thus, it is possible this matter could result in the cancellation of our trademark registration for BORU in the United States. As a result, it is not feasible to predict the final outcome, and there can be no assurance that these claims might not be finally resolved adversely to us, resulting in material liability to our operations.

Furthermore, we may become involved in litigation from time to time relating to claims arising in the ordinary course of our business. These claims, even if not meritorious, could result in the expenditure of significant financial and managerial resources.

Item 1A.    Risk Factors

Not applicable.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3.    Defaults Upon Senior Securities

Not applicable.

Item 4.    Submission of Matters to a Vote of Security Holders

Not applicable.

Item 5.    Other Information

Not applicable.

Item 6.    Exhibits

Exhibit Number			Description
31.1			Certification Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2			Certification Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

34

---

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			CASTLE BRANDS INC.
			By:			/s/ Keith A. Bellinger
						Keith A. Bellinger
						President and Chief Operating Officer
						(Duly Authorized Officer and Principal Financial Officer)
						August 14, 2007

---

Table of Contents

EXHIBIT INDEX

Exhibit Number			Description
31.1			Certification Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2			Certification Pursuant to Rule 13a-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

---